A Multicenter, Open-Label, Randomized Controlled Trial of a Dual Early Intervention Approach Combining Standard Care and Corticosteroids for Elderly Patients with Mild to Moderate COVID-19 (BEAT-COV Study) - Quiz - MDSpire

A Multicenter, Open-Label, Randomized Controlled Trial of a Dual Early Intervention Approach Combining Standard Care and Corticosteroids for Elderly Patients with Mild to Moderate COVID-19 (BEAT-COV Study)

  • By

  • Qiaoling Ruan

  • Yanliang Zhang

  • Tingting Zhao

  • Feng Zhu

  • Xi Liu

  • Ran Cao

  • Yongzhong Li

  • Xiaoqiang Zhang

  • Wei Song

  • Jiawei Geng

  • Deming Zou

  • Yuanyuan Li

  • Liaoyun Zhang

  • Chao Wu

  • Yuanbo Lan

  • Xiangchun Ding

  • Fuli Huang

  • Jiqin Wu

  • Feng Sun

  • Lingyun Shao

  • Wenhong Zhang

  • March 6, 2026

  • 0 min

Share

Original Source(s)

A Multicenter, Open-Label, Randomized Controlled Trial of a Dual Early Intervention Approach Combining Standard Care and Corticosteroids for Elderly Patients with Mild to Moderate COVID-19 (BEAT-COV Study)

  • by Qiaoling Ruan, Yanliang Zhang, Tingting Zhao, Feng Zhu, Xi Liu, Ran Cao, Yongzhong Li, Xiaoqiang Zhang, Wei Song, Jiawei Geng, Deming Zou, Yuanyuan Li, Liaoyun Zhang, Chao Wu, Yuanbo Lan, Xiangchun Ding, Fuli Huang, Jiqin Wu, Feng Sun, Lingyun Shao, Wenhong Zhang

  • March 6, 2026

Related Content

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

Fc-mediated antibody functions are associated with disease severity in COVID-19

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.